Collaborative Funding Awards
The Office of the Vice President for Research at UTSA is providing up to $110,000 in grants to start new and innovative collaborative and multidisciplinary research programs.
The lead PI must be a UTSA tenure or tenure-track faculty member. Co-PI's must be from outside the department, college, center or institute of the lead PI. Proposals will be accepted in two categories: 1.) Proposals from multiple departments within a single college and 2.) Proposals from multiple UTSA colleges, centers, or institutes or a single UTSA organization with collaborators from one or more outside organizations (e.g. Southwest Research Institute, UTHSCSA, or industry). Two awards within each category are anticipated. Maximum awards for Category 1 will be $25,000 and maximum awards for Category 2 will be $30,000. Funding will be used exclusively for research activities and not for non-research related or administrative costs. Funding from this program must be expended by the end of the FY in which awarded. Any remaining funding will be returned.
Authorized by the 77th Texas Legislature in 2003, the University of Texas System, the University of Texas Health Science Center at San Antonio (UTHSCSA) and the University of Texas at San Antonio (UTSA) formed the San Antonio Life Sciences Institute (SALSI) to promote greater scientific collaboration between the two institutions and to increase both the UTHSCSA's and UTSA's research-funding base with cross campus collaborative programs. This program aims to encourage interaction between investigators in support of the acquisition of established extramural, peer-reviewed research funding. Funding for support of SALSI by the Texas Legislature for the FY 2010-2011 biennium has allowed us to re-establish this grants program.
The purpose of the PCTCS program is to develop, monitor, and expand a process to facilitate and support pilot and collaborative translational and clinical studies that result in increased institutional and community-based trans-disciplinary research with a goal of improved health. Our strategy is to bring all IIMS pilot and collaborative study review and funding decisions into a single mechanism to allow maximum flexibility and programmatic balance. In addition to investigator-initiated applications, the PCTCS will also support the review and funding of applications submitted in response to RFAs from five other IIMS key function groups. The review process will be two-tiered. The initial review will be by a group of experts in the subject matter of the application using the NIH grading system. The second review will be by the IIMS Director, all of the Co-PIs and members of the Community Advisory Board and funding decisions will be based on scientific merit, as well as programmatic considerations, such as breadth and depth of the overall pilot study portfolio, community involvement, and balance among program areas.
The purpose of this function is to develop and sustain an innovative paradigm to facilitate availability and use of state-of-the-art technologies for translational research. We will provide funding in support of translational research that utilizes technology resources.
The Institute for Integration of Medicine & Science tracks a number of funding opportunities, both internal and external. This site includes links to such announcements.